Ondansetron Supplier-Buyer Network — Trade Flow Analysis

Name: Ondansetron Supplier-Buyer Trade Network Dataset — 537+ Indian Exporters, 16+ Importers, 157+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Ondansetron supplier network, Ondansetron buyers, pharmaceutical export India, Ondansetron trade data

TransData Nexus

Ondansetron

India Pharmaceutical Trade Intelligence

$121.0M537 Suppliers157 CountriesHS 30049035

ExportsIndia → UNITED STATES58.8%India → AUSTRALIA6.0%

ImportsUNITED STATES → India$21.1K UNITED KINGDOM → India$14.4K

#1 Buyer: GLENMARK PHARMACEUTICALS

Who Supplies Ondansetron? Top Manufacturers & Buyers 2026 — AUROBINDO PHARMA LTD Leads | TransData Nexus | TransData Nexus

1AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the first-largest Ondansetron exporter from India, with a market share of 9.9% and a total export value of $12.0M across 741 shipments. Their average shipment value of $16.2K is above the market average of $14.3K, suggesting premium or bulk contract pricing.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $2.9M across 181 shipments (24.4% of this supplier's total exports)

• RISING PHARMA HOLDINGS, INC. , — $2.9M across 179 shipments (24.2% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $2.9M across 178 shipments (24.1% of this supplier's total exports)

• AUROLOGISTICS LLC AUROBINDO PHARM — $2.0M across 125 shipments (16.8% of this supplier's total exports)

• RISING PHARMA HOLDINGS, INC. , — $1.3M across 78 shipments (10.5% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD's per-shipment value of $16.2K is 13% above the market average of $14.3K, consistent with large-order contracts or value-added formulations.

2GLENMARK PHARMACEUTICALS LIMITED

GLENMARK PHARMACEUTICALS LIMITED is the second-largest Ondansetron exporter from India, with a market share of 7.2% and a total export value of $8.7M across 635 shipments. Their average shipment value of $13.6K is below the market average of $14.3K, reflecting a high-volume, competitive pricing strategy.

GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• GLENMARK PHARMACEUTICALS INC USA — $3.6M across 266 shipments (41.9% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $3.2M across 235 shipments (36.9% of this supplier's total exports)

• AMERISOURCE HEALTH SERVICES DBA AME — $714.7K across 52 shipments (8.3% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC USA — $628.5K across 46 shipments (7.3% of this supplier's total exports)

• AMERISOURCE HEALTH SERVICES DBA AME — $493.8K across 36 shipments (5.7% of this supplier's total exports)

Key Insight: GLENMARK PHARMACEUTICALS LIMITED operates with high shipment frequency (635 shipments) at a per-shipment value of $13.6K, indicating a broad distribution network with many smaller, regular orders.

3AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED is the third-largest Ondansetron exporter from India, with a market share of 6.3% and a total export value of $7.6M across 244 shipments. Their average shipment value of $31.1K is above the market average of $14.3K, suggesting premium or bulk contract pricing.

AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AUROLOGISTICS LLC AUROBINDO PHARM — $2.7M across 86 shipments (35.3% of this supplier's total exports)

• RISING PHARMA HOLDINGS, INC. , — $2.0M across 66 shipments (27.0% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $1.1M across 36 shipments (14.9% of this supplier's total exports)

• AUROLOGISTICS LLC — $1.0M across 33 shipments (13.4% of this supplier's total exports)

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $713.0K across 23 shipments (9.4% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LIMITED's per-shipment value of $31.1K is 118% above the market average of $14.3K, consistent with large-order contracts or value-added formulations.

4BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED

BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED is the fourth-largest Ondansetron exporter from India, with a market share of 4.5% and a total export value of $5.5M across 272 shipments. Their average shipment value of $20.0K is above the market average of $14.3K, suggesting premium or bulk contract pricing.

BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• BAXTER DISTRIBUTION CENTRE EUROPE S — $2.3M across 116 shipments (42.6% of this supplier's total exports)

• BAXTER HEALTHCARE CORPORATION — $1.0M across 50 shipments (18.4% of this supplier's total exports)

• LABORATORIOS BAXTER — $928.9K across 46 shipments (17.0% of this supplier's total exports)

• ADVANCED TECHNOLOGY — $659.6K across 33 shipments (12.1% of this supplier's total exports)

• LABORATORIOS BAXTER — $539.7K across 27 shipments (9.9% of this supplier's total exports)

Key Insight: BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED's per-shipment value of $20.0K is 40% above the market average of $14.3K, consistent with large-order contracts or value-added formulations.

5GLAND PHARMA LIMITED

GLAND PHARMA LIMITED is the fifth-largest Ondansetron exporter from India, with a market share of 3.0% and a total export value of $3.6M across 101 shipments. Their average shipment value of $35.5K is above the market average of $14.3K, suggesting premium or bulk contract pricing.

GLAND PHARMA LIMITED serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AVET PHARMACEUTICALS INC — $1.4M across 39 shipments (38.1% of this supplier's total exports)

• AVET PHARMACEUTICALS INC — $1.4M across 38 shipments (37.6% of this supplier's total exports)

• EVERSANA LIFE SCIENCE SERVICES — $869.8K across 24 shipments (24.2% of this supplier's total exports)

Key Insight: GLAND PHARMA LIMITED's per-shipment value of $35.5K is 149% above the market average of $14.3K, consistent with large-order contracts or value-added formulations.

6DR.REDDY'S LABORATORIES LTD

DR.REDDY'S LABORATORIES LTD is the fifth-largest Ondansetron exporter from India, with a market share of 1.6% and a total export value of $2.0M across 213 shipments. Their average shipment value of $9.2K is below the market average of $14.3K, reflecting a high-volume, competitive pricing strategy.

DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• DR.REDDY'S LABORATOR — $616.2K across 67 shipments (31.3% of this supplier's total exports)

• DR. REDDYS LABORATOR — $442.5K across 48 shipments (22.5% of this supplier's total exports)

• DR.REDDY'S LABORATOR — $374.4K across 41 shipments (19.0% of this supplier's total exports)

• DR. REDDYS LABORATOR — $345.0K across 37 shipments (17.5% of this supplier's total exports)

• PREET RATTAN — $190.3K across 21 shipments (9.7% of this supplier's total exports)

Key Insight: DR.REDDY'S LABORATORIES LTD operates with high shipment frequency (213 shipments) at a per-shipment value of $9.2K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Ondansetron imports from India, with a total trade value of $71.2M across 1,492 shipments — representing a 58.8% share of all Ondansetron exports. The average shipment value of $47.7K is above the global average of $14.3K, indicating high-value procurement contracts or branded formulations. This market is served by 16 tracked buyers.

Named Ondansetron importers in United States: GLENMARK PHARMACEUTICALS INC., USA is the largest buyer, accounting for 10.7% ($7.6M) of this market's total imports.

• GLENMARK PHARMACEUTICALS INC., USA — $7.6M (10.7% of United States's total)

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $7.0M (9.9% of United States's total)

• AVET PHARMACEUTICALS INC — $5.8M (8.2% of United States's total)

Key Insight: United States's per-shipment average of $47.7K (234% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Ondansetron imports from India.

Primary Market

Secondary Market

2Australia

Australia ranks as the second-largest destination for Ondansetron imports from India, with a total trade value of $7.3M across 0 shipments — representing a 6.0% share of all Ondansetron exports. The average shipment value of $7.3M is above the global average of $14.3K, indicating high-value procurement contracts or branded formulations.

Key Insight: Australia's per-shipment average of $7.3M (50935% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Australia is a key market for Ondansetron imports from India.

Primary Market

Secondary Market

3South Africa

South Africa ranks as the third-largest destination for Ondansetron imports from India, with a total trade value of $7.0M across 9 shipments — representing a 5.7% share of all Ondansetron exports. The average shipment value of $772.5K is above the global average of $14.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Ondansetron importers in South Africa: RANBAXY PHARMACEUTICALS PTY LTD is the largest buyer, accounting for 29.4% ($2.0M) of this market's total imports.

• RANBAXY PHARMACEUTICALS PTY LTD — $2.0M (29.4% of South Africa's total)

• RANBAXY PHARMACEUTICALS PTY LTD., — $1.3M (19.2% of South Africa's total)

Key Insight: South Africa's per-shipment average of $772.5K (5305% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

South Africa is a key market for Ondansetron imports from India.

Primary Market

Secondary Market

4Canada

Canada ranks as the fourth-largest destination for Ondansetron imports from India, with a total trade value of $3.8M across 17 shipments — representing a 3.1% share of all Ondansetron exports. The average shipment value of $222.2K is above the global average of $14.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ondansetron importers in Canada: STERIMAX INC is the largest buyer, accounting for 30.1% ($1.1M) of this market's total imports.

• STERIMAX INC — $1.1M (30.1% of Canada's total)

Key Insight: Canada's per-shipment average of $222.2K (1454% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Ondansetron imports from India.

Primary Market

Secondary Market

5Belgium

Belgium ranks as the fifth-largest destination for Ondansetron imports from India, with a total trade value of $2.8M across 80 shipments — representing a 2.3% share of all Ondansetron exports. The average shipment value of $34.9K is above the global average of $14.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ondansetron importers in Belgium: BAXTER DISTRIBUTION CENTRE EUROPE S is the largest buyer, accounting for 96.9% ($2.7M) of this market's total imports.

• BAXTER DISTRIBUTION CENTRE EUROPE S — $2.7M (96.9% of Belgium's total)

Key Insight: Belgium's per-shipment average of $34.9K (144% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Ondansetron imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ondansetron.
2.Flow Mapping: 537 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 8,469 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 157 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

8,469 Verified Shipments

537 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Ondansetron

Ondansetron

Who Supplies Ondansetron? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Ondansetron — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Ondansetron? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Ondansetron Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1AUROBINDO PHARMA LTD

2GLENMARK PHARMACEUTICALS LIMITED

3AUROBINDO PHARMA LIMITED

4BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED

5GLAND PHARMA LIMITED

6DR.REDDY'S LABORATORIES LTD

From Indian Factories to Global Pharmacies — How Ondansetron Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Ondansetron Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Australia

3South Africa

4Canada

5Belgium

People Also Ask — Ondansetron Supplier & Trade Network

Ondansetron Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology